Current and Emerging Roles of BTK Inhibitors in CLL/SLL and MCL


Share

Program Content

Activities

  • Managing CLL and MCL With BTKi
    Current and Emerging Roles of BTK Inhibitors in CLL/SLL and MCL
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 13, 2023

  • BTK Inhibitors in Blood Cancer
    Current and Emerging Roles of BTK Inhibitors in CLL/SLL and MCL
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 12, 2023

    Expires: December 11, 2024

  • BTKi in CLL/SLL and MCL
    BTK Inhibitors in CLL/SLL and MCL: The Latest Guidance and Evidence for the Clinic
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 14, 2023

Faculty

cover img faculity

Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, Ohio

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme, LLC